Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_assertion type Assertion NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_head.
- NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_assertion description "[After 3 months of therapy, levels of left ventricular end diastolic diameter, NT-proBNP, CRP, Th1, Th1/Th2, IFN-?, T-bet mRNA and T-bet/GATA-3 mRNA decreased in the two CCI subgroups, but levels in the CCI intervention group were lower in comparison to the control group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_provenance.
- NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_assertion evidence source_evidence_literature NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_provenance.
- NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_assertion SIO_000772 23413906 NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_provenance.
- NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_assertion wasDerivedFrom befree-20140225 NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_provenance.
- NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_assertion wasGeneratedBy ECO_0000203 NP442092.RAAg8fjycXC1yO4kpA02nKEhg0aQVLLq2huv2UVmgcF94130_provenance.